I now have comprehensive data from multiple authoritative textbooks. Let me compile the full answer.
Hyperemesis Gravidarum (HG)
Definition
Hyperemesis gravidarum is the severe end of the nausea and vomiting of pregnancy (NVP) spectrum. It is defined by:
- Persistent, severe vomiting requiring medical intervention
- Weight loss >5% of pre-pregnancy body weight
- Ketonuria (starvation metabolism)
- Fluid, electrolyte, and acid-base imbalances
- Associated features: hypersalivation (ptyalism), hyperolfaction, altered taste
It differs from ordinary morning sickness, which affects 60-70% of pregnant women and resolves without significant metabolic consequences. - Sleisenger and Fordtran's GI and Liver Disease
Epidemiology
-
Occurs in ~0.5-1% of live births (second most common cause of pregnancy-related hospitalization)
-
Symptoms begin weeks 4-6, peak weeks 8-12, and typically resolve by week 14-16
-
Up to 20% of affected patients have vomiting that persists until delivery
-
Leads to elective pregnancy termination in ~2% of cases
-
Higher risk groups: young, nulliparous, non-Caucasian women; those with hyperthyroidism, psychiatric disorders, diabetes, GI disorders, or asthma
-
Recurrence: 15-19% in subsequent pregnancies if first pregnancy was affected (vs. 0.7% if first pregnancy was unaffected)
-
Creasy & Resnik's Maternal-Fetal Medicine
Risk Factors / Associated Conditions
| Factor | Mechanism/Note |
|---|
| Multiple gestation | Higher HCG levels |
| Singleton female fetus | Higher HCG |
| Gestational trophoblastic disease | Markedly elevated HCG |
| Trisomy 21, triploidy | Karyotypic associations |
| Hydrops fetalis | Associated condition |
| H. pylori infection | Increased prevalence; eradication may help |
| Familial history | Genetic predisposition |
| Obesity | Higher estrogen levels |
Pathophysiology
The etiology is multifactorial:
Hormonal:
- HCG - symptoms worsen during peak HCG; HCG alpha-subunit has TSH-like activity, explaining transient gestational thyrotoxicosis (abnormal TFTs in ~two-thirds of HG patients - does not usually require treatment)
- Estrogen/progesterone - slow GI transit and alter gastric motility
- Gut hormones (ghrelin, leptin) also implicated
Helicobacter pylori:
- Two meta-analyses confirm increased H. pylori prevalence in HG; eradication may reduce vomiting episodes
GI dysmotility and psychosocial factors also contribute
Genetic predisposition suggested by familial clustering
- Sleisenger and Fordtran's GI and Liver Disease
Clinical Features
Symptoms:
- Severe, persistent nausea and vomiting
- Dry mouth, hypersalivation (ptyalism), hyperolfaction
- Triggers: olfactory, auditory, and visual stimuli
- Pyrosis, hematemesis in some
Signs:
- Dry mucous membranes, poor skin turgor, hypotension
- Tachycardia, muscle wasting in severe cases
Scoring: The PUQE score (Pregnancy-Unique Quantification of Nausea and Emesis) - counts hours of nausea and episodes of emesis/retching per day - is useful for tailoring therapy.
Laboratory Findings
| Test | Finding |
|---|
| Urinalysis | Ketonuria, elevated specific gravity |
| Serum electrolytes | Hypokalemia, hyponatremia, contraction alkalosis, elevated anion gap |
| Serum aminotransferases & bilirubin | Elevated in 25-40% of cases |
| Amylase | Elevated in ~25% (excess salivary gland production) |
| Renal function | May be abnormal in severe cases |
| Thyroid function | Abnormal (transient gestational thyrotoxicosis) in ~two-thirds |
Differential Diagnosis
- Molar pregnancy, hydatidiform mole
- Hyperthyroidism
- Viral hepatitis, liver disease
- Gastroenteritis, peptic ulcer disease
- Appendicitis (especially if lateralized pain)
- Urinary tract infection
- Vestibular disorders (if vertigo predominates)
Management
Step 1 - Dietary and Non-Pharmacologic Measures
- Multiple small meals; avoid empty stomach
- High-carbohydrate diet
- Avoid offensive odors; separate solid and liquid intake
- Ginger has documented benefit
Step 2 - IV Fluid Resuscitation (for hospitalization criteria: hypotension, tachycardia, ketosis, weight loss)
- 2 L of Lactated Ringer's infused over 3-5 hours; subsequent rate to maintain urine output >100 mL/h
- Thiamine 100 mg IV BEFORE any dextrose infusion (to prevent Wernicke encephalopathy)
- After initial LR bolus, switch to D5/0.45NS until ketonuria clears
- Replete potassium (for hypokalemia) and magnesium/calcium (monitor regularly)
- Correct hyponatremia slowly (risk of central pontine myelinolysis if corrected too rapidly)
Step 3 - Pharmacologic Antiemetics (stepwise)
| Drug class | Agent | Notes |
|---|
| First-line | Pyridoxine (B6) 10-25 mg TID | Often combined with doxylamine (Diclegis/Bonjesta) |
| Phenothiazines | Prochlorperazine, chlorpromazine | Good safety profile |
| Dopamine antagonist | Metoclopramide | Avoid prolonged use (tardive dyskinesia risk) |
| Antihistamines | Promethazine, diphenhydramine | Sedation is limiting side effect |
| 5-HT3 antagonist | Ondansetron | For non-responders to above; safety supported by controlled trial and case series |
Step 4 - Refractory/Recalcitrant Cases
Corticosteroids:
- Methylprednisolone 16 mg PO/IV q8h x 3 days then 2-week taper
- IV hydrocortisone 300 mg/day x 3 days then taper over 1 week
- Results are conflicting across trials, but some show reduced readmission
- Caution in first trimester - possible weak association with facial clefting (1-2 per 1000 treated)
- Avoid during organogenesis if possible
Other options explored:
- Transdermal clonidine (limited data)
- Oral mirtazapine (limited data, fetal effects unknown)
- H. pylori testing and eradication (benefit not fully established)
Step 5 - Nutritional Support
- Enteral nutrition via NG tube - preferred over parenteral, for patients who cannot maintain weight despite medical therapy
- Total Parenteral Nutrition (TPN) - reserved as last resort due to significant complications:
- Catheter sepsis (~25%)
- Venous thrombosis (~3%)
- PICC lines: overall complication rate 50%, severe complications 22%
Complications
Maternal:
- Wernicke encephalopathy (thiamine deficiency) - apathy, drowsiness, ophthalmoplegia, nystagmus, ataxia, memory loss, catatonia - typically presents weeks 14-20
- Mallory-Weiss tears / hematemesis
- Boerhaave syndrome (esophageal rupture)
- Central pontine myelinolysis
- Retinal hemorrhage
- Spontaneous pneumomediastinum
- Gestational polyneuropathy
- Depression, PTSD during pregnancy and postpartum
- Hypokalemia-induced cardiac or respiratory arrest (rare)
Fetal/Neonatal (from poor maternal weight gain):
- Low birth weight
- Small for gestational age
- Prematurity
- Low 5-minute Apgar scores
- Vitamin K deficiency and bleeding diatheses (if maternal nutrition severely depleted)
Transient Gestational Thyrotoxicosis
A specific finding in HG deserving mention: because the HCG alpha-subunit has TSH-like activity, elevated HCG levels suppress TSH and mildly raise free T4. This transient hyperthyroidism of hyperemesis gravidarum resolves with control of vomiting and does not require antithyroid treatment. - Tintinalli's Emergency Medicine
Fetal Outcomes
Women with HG who gain <7 kg total during pregnancy have significantly higher rates of:
- Low birth weight
- Prematurity
- Small for gestational age
- Apgar scores <7
This is confirmed by a meta-analysis. - Creasy & Resnik's Maternal-Fetal Medicine
Recent Evidence (2024-2026)
A 2026 network meta-analysis (
PMID 42075106) comparing pharmacological and non-pharmacological interventions for NVP (including HG) is among the most current systematic evaluations of relative treatment effectiveness.
A 2026 consensus study (
PMID 42399837) established a
core outcome measurement set for HG research, which should improve comparability of future trials.
Sources: Creasy & Resnik's Maternal-Fetal Medicine; Sleisenger and Fordtran's GI and Liver Disease; Rosen's Emergency Medicine; Bradley and Daroff's Neurology in Clinical Practice; Tintinalli's Emergency Medicine